- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
BCL-2 as therapeutic target for hematological malignancies ; volume:11 ; number:1 ; day:11 ; month:5 ; year:2018 ; pages:1-15 ; date:12.2018
Journal of hematology & oncology ; 11, Heft 1 (11.5.2018), 1-15, 12.2018
- Urheber
-
Perini, Guilherme Fleury
- Beteiligte Personen und Organisationen
-
Ribeiro, Glaciano Nogueira
Pinto Neto, Jorge Vaz
Campos, Laura Tojeiro
Hamerschlak, Nelson
SpringerLink (Online service)
- DOI
-
10.1186/s13045-018-0608-2
- URN
-
urn:nbn:de:101:1-2018071518461616448089
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Perini, Guilherme Fleury
- Ribeiro, Glaciano Nogueira
- Pinto Neto, Jorge Vaz
- Campos, Laura Tojeiro
- Hamerschlak, Nelson
- SpringerLink (Online service)
Ähnliche Objekte (12)
Combination of BCL-2 inhibitors and immunotherapy: a promising therapeutic strategy for hematological malignancies
Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies
Deubiquitinases in hematological malignancies
Natural and synthetic compounds modulating targets associated with hematological malignancies
Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance
The role of proteostasis in hematological malignancies and the therapeutic implications
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Combination of BCL-2 inhibitors and immunotherapy: a promising therapeutic strategy for hematological malignancies
Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies
Deubiquitinases in hematological malignancies
Natural and synthetic compounds modulating targets associated with hematological malignancies
Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance
The role of proteostasis in hematological malignancies and the therapeutic implications
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Combination of BCL-2 inhibitors and immunotherapy: a promising therapeutic strategy for hematological malignancies
Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies
Deubiquitinases in hematological malignancies
Natural and synthetic compounds modulating targets associated with hematological malignancies
Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance
The role of proteostasis in hematological malignancies and the therapeutic implications
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism